EFA selected as a European Commission HTA stakeholder and new EFA Task Force
We are delighted about the European Commission confirmation that EFA is a suitable stakeholder to become member of the Health Technology Assessment pool...
Our response to the Commission consultation on excise duties applied to manufactured tobacco
EFA has replied, in partnership with ENSP, to the European Commission public consultation on excise duties applied to manufactured tobacco. From our patients’...
How to communicate health risks of air pollution? Our views at WHO meeting
In February we were invited to a close round table organised by the World Health Organisation European division in Bonn on the “Software AirQ+ for the...
Universal Health Coverage for all! An EPF campaign
The European Patients Forum has launched a public campaign on access to healthcare. The campaign was launched in a public event at the European Parliament...
Our evaluation to the Commission Health Programme
In February, we responded to the European Commission public consultation on the mid-term evaluation of the third public health programme 2014-2020. The...
COPD MOVE, we are looking for COPD patient ambassadors
During 2017 we will promote physical exercise to improve the quality of life of patients living with COPD. The first videos have already been realised...
myAirCoach will be featured at CeBIT
myAirCoach consortium will meet in Brussels for the second year technical review with the European Commission that will be held on the 7th of March.
The...
Food allergy tips from UK youth ambassadors
Anaphylaxis Campaign youth ambassadors scheme was launched in 2016. They are a team of young people that produce social media and website communications...
EFA alignment meeting Estonia
Our Susanna Palkonen went to Estonia in February to meet the Estonian allergy and respiratory groups to introduce the value of joining our network and...
ABBA launches a national “Breathe Freely” campaign in Bulgaria
EFA Bulgarian Member ABBA has launched an annual national campaign to inform about respiratory diseases and advance care options for patients. The campaign...
Moisturisers for eczema: they do work!
The dry and itchy skin in people with eczema makes it common sense to use a moisturiser. However, it wasn’t known if moisturisers really are beneficial...
FENAER participates at the Spanish Respiratory Society Congress
EFA Spanish Member FENAER brought the perspective of respiratory patients to the SEPAR Pacientes meeting. Mª Emilia Carretero, FENAER Board Member highlighted...
Respira turns 10!
EFA Member the Portuguese COPD patients association RESPIRA has celebrated its 10th anniversary in Lisbon on the 23rd February. During the meeting they...
Changing the perception of COPD: COPD Move by Patients! - EFA project
{tab EN}
Physical activity is recognised to bring relevant benefit to COPD patients. However, breathlessness during physical activity limit patients’...
1 in 3 MEPs signed the written declaration on chronic respiratory diseases
The Written Declaration 115/2016 on chronic respiratory diseases, an initiative of a group of Members of the European Parliament to gather support to prevention...
The first EP event of the year put the focus on health: Act. Believe. Care.
Chronic respiratory diseases need public policy solutions at European level to respond to increasing disease prevalence, unmet treatment needs, high cost...
Great satisfaction among EFA Capacity Building participants
EFA’s 2016 Capacity Building project ended in January 2017 with a last session held in Kent, United Kingdom, together with our member Allergy UK. In...
Our response to the European Commission HTA consultation
The European Commission has launched a consultation on strengthening EU cooperation on Health Technology Assessment (HTA), a specialty to measure the added...
MyAirCoach will be tested in 2017
In November 2016, we met in Manchester with our partners of the Horizon 2020 project myAirCoach to track the status quo in all work-packages, the main...
IMI looks into what patients bring to medicines
The Innovative Medicines Initiative launched in December its 10th call for proposals under IMI 2. We especially welcome one of the topics of this call:...